The Image Guided Radiotherapy Market is growing as healthcare providers look for ways to make radiation treatment more accurate and patient-specific. The market reached USD 3.27 billion in 2024 and is expected to increase from USD 3.43 billion in 2025 to USD 5.53 billion by 2035, representing a 4.89% CAGR during the forecast period. Rising cancer cases and improvements in imaging technology are among the key factors supporting demand. For more information, see the Image Guided Radiotherapy Market report.

Modern image guided systems are helping radiation specialists see and target tumors with greater accuracy. CT remains the largest technology segment because of its established role in tumor localization and treatment planning, while MRI is showing faster adoption because of its strong soft-tissue imaging capabilities. Ultrasound and fusion imaging also contribute to specialized clinical applications.

The market is closely connected to the development of personalized oncology. Tumor imaging is the largest application, providing important information for identifying and characterizing treatment targets. Radiotherapy planning is growing quickly as hospitals adopt advanced imaging and planning techniques that can support more individualized radiation strategies, while treatment verification helps confirm that therapy is delivered to the intended anatomical area.

Regional development is creating different opportunities across the industry. North America held the largest market valuation at USD 1.56 billion in 2024 and is projected to reach USD 2.66 billion by 2035. Europe is also well established, while Asia-Pacific is expected to see strong expansion as countries increase healthcare investment and improve access to advanced oncology technologies.

Future growth is likely to depend on combining imaging, treatment planning, and digital technologies into smoother clinical workflows. AI-driven planning software, real-time imaging, adaptive radiotherapy, and remote consultation capabilities are among the opportunities highlighted for the market. As healthcare systems continue upgrading cancer treatment infrastructure, providers may increasingly seek integrated platforms that improve precision while supporting efficient clinical operations.

Strengthen your strategy with data-backed research insights:

Flow Cytometer Reagents Market Share

Real-World Evidence Market Trends

Rapid Diagnostics Market Growth

Vacuum blood collection tube Market Demand

Hospital Services Market Volume